Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Consumer Cyclical Healthcare Advertising Agencies Biotechnology

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc.

Bullboard Posts

Post by Leerykevinon May 04, 2020 7:35pm

175 Views

Post# 30985840

highoutput

highoutput (70)

April 20, 2020 - 12:46 PM

62 Reads

Post# 30930287

RE:RE:RE:dont sell for pennies u will regret it this is chump change!

That may happen but at this point this company is purely a spec play. It's a penny stock.

Bullboard Posts

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide

NervGen Pharma: Proof that NVG-291 works?

NervGen Pharma: Proof that NVG-291 works?

Invest wiser with BMO's InvestorLine Platform features

Invest wiser with BMO's InvestorLine Platform features

A potential breakthrough in spinal cord and optic nerve injury treatment

A potential breakthrough in spinal cord and optic nerve injury treatment

Eminent acquires promising Nevada gold project

Eminent acquires promising Nevada gold project